Harnessing the unique biology of CD73 for improving endometrial cancer outcomes

被引：0
作者：
Bowser, Jessica L.
Lee, Hannah N.
Hirsch, Rebecca H.
Zhang, Xingyuan
Broaddus, Russell R.
Kurnit, Katherine C.
Crumley, Suzanne M.
Premsankar, Sunthoshini
Rabjohns, Emily M.
Chiou, Lilly F.
Vaziri, Cyrus
机构：
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 05期
关键词：
D O I：
10.1158/1557-3265.ENDO24-IA022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA022
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis
    Yang, Qing
    Du, Jun
    Zu, Lingling
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (04) : 811 - 814
  • [42] Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 16 (01): : 10 - 11
  • [43] Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
    Gardani, Carla Fernanda Furtado
    Pedrazza, Eduardo Luiz
    Paz, Victoria Santos
    Zanirati, Gabriele Goulart
    da Costa, Jaderson Costa
    Andrejew, Roberta
    Ulrich, Henning
    Scholl, Juliete Nathali
    Figueiro, Fabricio
    Rockenbach, Liliana
    Morrone, Fernanda Bueno
    PHARMACEUTICALS, 2023, 16 (11)
  • [44] CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer
    DelGiorno, Kathleen
    CANCER RESEARCH, 2023, 83 (07) : 977 - 978
  • [45] CD73 as a Novel Prognostic Biomarker for Human Colorectal Cancer Reply
    Wu, Xian-Rui
    He, Xiao-Sheng
    Chen, Yu-Feng
    Wu, Xiao-Jian
    Lan, Ping
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (07) : 920 - 920
  • [46] The regulation of CD73 in non-small cell lung cancer
    Han, Yumin
    Lee, Trevor
    He, Yongfeng
    Raman, Renuka
    Irizarry, Adriana
    Martin, M. Laura
    Giaccone, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2022, 170 : 91 - 102
  • [47] Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
    Ploeg, Emily Maria
    Samplonius, Douwe Freerk
    Xiong, Xiao
    Ke, Xiurong
    Hendriks, Mark Alexander Johannes Martinus
    Britsch, Isabel
    van Wijngaarden, Anne Paulien
    Zhang, Hao
    Helfrich, Wijnand
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [48] Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
    Terp, Mikkel G.
    Olesen, Kristina A.
    Arnspang, Eva C.
    Lund, Rikke R.
    Lagerholm, B. Christoffer
    Ditzel, Henrik J.
    Leth-Larsen, Rikke
    JOURNAL OF IMMUNOLOGY, 2013, 191 (08) : 4165 - 4173
  • [49] Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
    Fons, Pierre
    Bell, Andrew
    Esquerre, Michael
    Versluys, Stephanie
    Bertrand, Florie
    Schreyer, Adrian
    Hopkins-Navratilova, Iva
    Hernani, Leonardo-Silvestre
    Bergeaud, Celia
    Poussereau-Pomie, Celine
    Marchand, Ghislaine
    Robinson, Sean
    Culurgioni, Simone
    Cox, Richard
    Besnard, Jeremy
    Payne, Andrew
    Ray, Peter
    Pelissier, Emilie
    Paillasse, Michael
    Lisztwan, Joanna
    Johnstone, Craig
    Whittaker, Mark
    Hopkins, Andrew
    CANCER RESEARCH, 2019, 79 (13)
  • [50] Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints
    Baghbani, Elham
    Noorolyai, Saeed
    Shanehbandi, Dariush
    Mokhtarzadeh, Ahad
    Aghebati-Maleki, Leili
    Shahgoli, Vahid Khaze
    Brunetti, Oronzo
    Rahmani, Shima
    Shadbad, Mahdi Abdoli
    Baghbanzadeh, Amir
    Silvestris, Nicola
    Baradaran, Behzad
    LIFE SCIENCES, 2021, 282
12345